Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer

por Becker, Marc A., Hou, Xiaonan, Tienchaianada, Piyawan, Haines, Brian B., Harrington, Sean C., Weroha, S. John, Sathyanarayanan, Sriram, Haluska, Paul
Publicado 2016

T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity

por Cemerski, Saso, Zhao, Shuxia, Chenard, Melissa, Laskey, Jason, Cui, Long, Shukla, Rinkan, Haines, Brian, Hsieh, Edward, Beaumont, Maribel, Mattson, Jeanine, Blumenschein, Wendy, Hirsch, Heather, Fayadat-Dilman, Laurence, Liang, Linda, De Waal Malefyt, Rene
Publicado 2015

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

por Loboda, Andrey, Nebozhyn, Michael, Klinghoffer, Rich, Frazier, Jason, Chastain, Michael, Arthur, William, Roberts, Brian, Zhang, Theresa, Chenard, Melissa, Haines, Brian, Andersen, Jannik, Nagashima, Kumiko, Paweletz, Cloud, Lynch, Bethany, Feldman, Igor, Dai, Hongyue, Huang, Pearl, Watters, James
Publicado 2010

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability

por Kennedy, Edward M., Farkaly, Terry, Grzesik, Peter, Lee, Jennifer, Denslow, Agnieszka, Hewett, Jacqueline, Bryant, Jeffrey, Behara, Prajna, Goshert, Caitlin, Wambua, Daniel, De Almeida, Ana, Jacques, Judith, Deavall, Damian, Rottman, James B., Glorioso, Joseph C., Finer, Mitchell H., Haines, Brian B., Quéva, Christophe, Lerner, Lorena
Publicado 2020

Observation of persistent species temperature separation in inertial confinement fusion mixtures

por Haines, Brian M., Shah, R. C., Smidt, J. M., Albright, B. J., Cardenas, T., Douglas, M. R., Forrest, C., Glebov, V. Yu, Gunderson, M. A., Hamilton, C. E., Henderson, K. C., Kim, Y., Lee, M. N., Murphy, T. J., Oertel, J. A., Olson, R. E., Patterson, B. M., Randolph, R. B., Schmidt, D. W.
Publicado 2020

Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer

por Kennedy, Edward M., Denslow, Agnieszka, Hewett, Jacqueline, Kong, Lingxin, De Almeida, Ana, Bryant, Jeffrey D., Lee, Jennifer S., Jacques, Judy, Feau, Sonia, Hayes, Melissa, McMichael, Elizabeth L., Wambua, Daniel, Farkaly, Terry, Rahmeh, Amal A, Herschelman, Lauren, Douglas, Danielle, Spinale, Jacob, Adhikari, Sanmit, Deterling, Jessica, Scott, Matt, Haines, Brian B., Finer, Mitchell H., Ashburn, Ted T, Quéva, Christophe, Lerner, Lorena
Publicado 2022

Combination of EP(4) antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells

por Wang, Yun, Cui, Long, Georgiev, Peter, Singh, Latika, Zheng, Yanyan, Yu, Ying, Grein, Jeff, Zhang, Chunsheng, Muise, Eric S., Sloman, David L., Ferguson, Heidi, Yu, Hongshi, Pierre, Cristina St., Dakle, Pranal J, Pucci, Vincenzo, Baker, James, Loboda, Andrey, Linn, Doug, Brynczka, Christopher, Wilson, Doug, Haines, Brian B, Long, Brian, Wnek, Richard, Sadekova, Svetlana, Rosenzweig, Michael, Haidle, Andrew, Han, Yongxin, Ranganath, Sheila H.
Publicado 2021

Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry

por Kluk, Michael J., Ashworth, Todd, Wang, Hongfang, Knoechel, Birgit, Mason, Emily F., Morgan, Elizabeth A., Dorfman, David, Pinkus, Geraldine, Weigert, Oliver, Hornick, Jason L., Chirieac, Lucian R., Hirsch, Michelle, Oh, David J., South, Andrew P., Leigh, Irene M., Pourreyron, Celine, Cassidy, Andrew J., DeAngelo, Daniel J., Weinstock, David M., Krop, Ian E., Dillon, Deborah, Brock, Jane E., Lazar, Alexander J. F., Peto, Myron, Cho, Raymond J., Stoeck, Alexander, Haines, Brian B., Sathayanrayanan, Sriram, Rodig, Scott, Aster, Jon C.
Publicado 2013